In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Effects of Low-dose Unfractionated Heparin on Early Brain Injury After Subarachnoid Hemorrhage in Mice

    Final Number:
    158

    Authors:
    Orhan ALTAY MD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2015 Annual Meeting

    Introduction: There is no proven effective therapy to prevent early brain injury (EBI) after subarachnoid hemorrhage (SAH) despite extensive research efforts. Sphingosine kinase (SphK) 1 has been reported as an important signaling node in anti-apoptotic signaling. Heparin is a pleiotropic drug that antagonizes many pathophysiological mechanisms. In this study, we evaluated if heparin prevents EBI after SAH by anti-apoptotic mechanisms including SphK1.

    Methods: This study used 135 8-week-old male CD-1 mice. We induced SAH with endovascular perforation in mice and randomly assigned animals to sham-operated (n = 23), SAH + vehicle (n = 35), SAH + 10U heparin pretreatment (n = 11), SAH + 30U heparin pretreatment (n = 14), SAH + 10U heparin posttreatment (n = 30), and SAH + 30U heparin posttreatment (n = 22). At 24 hours post-SAH, neurological scores, brain water content and Evans blue extravasation were evaluated. Also, the expression of SphK, phosphorylated Akt, and cleaved caspase-3 was determined by Western blotting and neuronal cell death was examined by terminal deoxynucleoti¬dyl transferase–mediated uridine 5’-triphosphate-biotin nick end-labeling staining.

    Results: Low-dose heparin pre- and post- treatment significantly improved neurobehavioral function and brain edema at 24 hours after SAH. Moreover, low-dose heparin posttreatment attenuated blood-brain barrier disruption and neuronal cell death in the cortex, associated with an increase in SphK1 and phosphorylated Akt, and a decrease in cleaved caspase-3. High-dose heparin had a tendency for increased SAH, which aggravated brain injury and therefore obscured the neuroprotective effects by heparin.

    Conclusions: Low-dose heparin posttreatment may decrease the development of post-SAH EBI through an¬ti-apoptotic mechanisms including sphingosine-related pathway activation, implying its efficacy for early prevention of brain injury after acute aneurysm rupture in a clinical setting.

    Patient Care: Low-dose heparin posttreatment may decrease the development of post-SAH EBI through anti-apoptotic mechanisms including sphingosine-related pathway activation.

    Learning Objectives: 1)Early prevention of brain injury after acute aneurysm rupture is important for lifesaving in a clinical setting. 2)Low-dose heparin effect mechanism may implicate with sphingosine-related pathway activation. 3)Low-dose heparin posttreatment may decrease the development of post-SAH EBI through anti-apoptotic mechanisms including sphingosine-related pathway activation

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy